|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/12 | (2006.01) |
| C07D 405/12 | (2006.01) | ||
| C07D 409/12 | (2006.01) | ||
| A61K 31/4155 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 19/02 | (2006.01) |
| (11) | Number of the document | 2117523 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08729249.6 |
| Date of filing the European patent application | 2008-02-07 | |
| (97) | Date of publication of the European application | 2009-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2014-06-25 |
| (46) | Date of publication of the claims translation | 2014-09-25 |
| (86) | Number | PCT/US2008/053269 |
| Date | 2008-02-07 |
| (87) | Number | WO 2008/098104 |
| Date | 2008-08-14 |
| (30) | Number | Date | Country code |
| 888586 P | 2007-02-07 | US |
| (72) |
SEEFELD, Mark, Andrew, US
ROUSE, Meagan, B., US
HEERDING, Dirk, A., US
PEACE, Simon, GB
YAMASHITA, Dennis, S., US
MCNULTY, Kenneth, C., US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | AKT aktyvumo inhibitoriai |
| INHIBITORS OF AKT ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2018-02-06 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-02-07 |